Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Clover Health Investments Co (CLOV)

203 + Investors. Track Smart Money conviction in CLOV. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +16
Streak
1Q ▲
Buyers last Q
56%

Smart Money Signals — CLOV

Based on 205 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added CLOV than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
205 hedge funds hold CLOV right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +6% more funds vs a year ago

fund count last 6Q
+11 new funds entered over the past year (+6% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 56% buying

107 buying85 selling
Last quarter: 107 funds bought or added vs 85 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+16 vs last Q)

new funds entering per quarter
Funds opening a new CLOV position: 52 → 32 → 31 → 47. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

48% of holders stayed for 2+ years

■ 48% conviction (2yr+) ■ 30% medium ■ 22% new
98 out of 205 hedge funds have held CLOV for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -2%, value -27%

Value
-26%
Shares
-1%
Last quarter: funds added -2% more shares while total portfolio value only changed -27%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~47 new funds/quarter

53 → 52 → 32 → 31 → 47 new funds/Q
New funds entering each quarter: 52 → 32 → 31 → 47. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 60% veterans vs 27% newcomers

■ 60% veterans ■ 13% 1-2yr ■ 27% new
Entry-cohort mix of 215 holders: 129 (60%) are 2+ year veterans, 29 entered 1–2 years ago, and 57 (27%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 43% AUM from top-100 funds

43% from top-100 AUM funds
41 of 204 holders are among the 100 largest funds by AUM, controlling 43% of total institutional value in CLOV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.6
out of 10
Low Exit Risk
Exit risk score 3.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CLOV

In 2026 Q1, 107 hedge funds were net buyers of CLOV (47 opened a new position, 60 added to an existing one), while 85 reduced or exited (54 trimmed, 31 sold completely) — a 56% buyer ratio, indicating a slight buying edge. 43% of total institutional value in CLOV is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +16 funds (more new holders than closures). Total institutional holders: 205.

Hedge Fund Ownership: CLOV

How many hedge funds hold CLOV — quarterly history vs. share price
Quarterly hedge fund ownership of CLOV vs. share price

Market Analysis: CLOV

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CLOV

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Clover Health Investments Co (CLOV) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CLOV has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 75d ago
CLOV
+168.8%
XLV
+4.9%

CLOV outperformed XLV by +163.9% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 30d ago
CLOV
+37.1%
XLV
+6.0%

Since the filing became public, CLOV outperformed XLV by +31.1% .

Interpretation: The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

22 top-rated funds 0 high-conviction
Consensus
5.9
/ 10
breadth
×
Elite
0.1
/ 10
conviction
Hedge Fund Positioning: CLOV
203 + Investors

Track Smart Money conviction in CLOV. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 203 189 7.41%
13F Shares 134M 136M -1.51%
Total Value $233M $318M -26.74%
New Positions 45 31 +14
Increased Positions 57 60 -3
Closed Positions 31 38 -7
Reduced Positions 53 56 -3
Total Calls 6 10 -40.0%
Total Puts 5 5 -
PUT/CALL Ratio 0.83 0.5 Neutral

Statistics: CLOV

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

203 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CLOV. Verified SEC 13F-HR filings.

QUARTER:
Top 25 CLOV holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Gmt Capital Corp 0.10% 1,305,200 $2.3M
2 Palacios Wealth Management, LLC 0.09% 51,624 $142K
3 EntryPoint Capital, LLC 0.08% 156,517 $275K
4 Sage Rhino Capital LLC 0.07% 211,440 $372K
5 R Squared Ltd 0.04% 37,442 $66K
6 Atom Investors LP 0.03% 254,959 $449K
7 Turtle Creek Wealth Advisors, LLC 0.03% 220,000 $387K
8 Viewpoint Capital Management LLC 0.02% 30,000 $53K
9 Quantbot Technologies LP 0.02% 323,281 $569K
10 marrick wealth, LLC 0.02% 15,000 $26K
11 Silverleafe Capital Partners, LLC 0.02% 40,000 $70K
12 State of Wyoming 0.02% 93,213 $164K
13 Landscape Capital Management, L.L.C. 0.02% 159,477 $281K
14 Headlands Technologies LLC 0.01% 60,313 $106K
15 Fortress Private Ledger, LLC 0.01% 20,200 $36K
16 Ketron Financial 0.01% 16,708 $29K
17 Alteri Wealth LLC 0.01% 18,275 $32K
18 Renaissance Technologies LLC 0.01% 3,401,541 $6.0M
19 Choreo, LLC 0.01% 386,602 $680K
20 Boothbay Fund Management, LLC 0.01% 339,402 $597K
21 SeaCrest Wealth Management, LLC 0.01% 41,100 $72K
22 FreeGulliver LLC 0.01% 10,000 $18K
23 Hrt Financial LP 0.01% 1,667,691 $2.9M
24 Strategic Family Wealth Counselors, L.L.C. 0.01% 12,263 $22K
25 Axq Capital, LP 0.00% 20,861 $37K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Clover Health Investments Co (CLOV)

What does the Smart Money Trend signal show for CLOV?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added CLOV than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CLOV?

Slight buying edge — 56% buying: Last quarter: 107 funds bought or added vs 85 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CLOV holders?

Elite ownership — 43% AUM from top-100 funds: 41 of 204 holders are among the 100 largest funds by AUM, controlling 43% of total institutional value in CLOV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held CLOV?

48% of holders stayed for 2+ years: 98 out of 205 hedge funds have held CLOV for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Clover Health Investments Co (CLOV) following the 2026 Q1 hedge fund 13F filings?

As of today, CLOV has moved +37.1% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of +31.1%. Since the quarter end (March 31, 2026), CLOV has gained +168.8% vs +4.9% for XLV. The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →